822 related articles for article (PubMed ID: 31735357)
1. Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}.
Afsan Z; Roisnel T; Tabassum S; Arjmand F
Bioorg Chem; 2020 Jan; 94():103427. PubMed ID: 31735357
[TBL] [Abstract][Full Text] [Related]
2. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
Tabassum S; Zaki M; Afzal M; Arjmand F
Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
[TBL] [Abstract][Full Text] [Related]
3. Copper (II)-based halogen-substituted chromone antitumor drug entities: Studying biomolecular interactions with ct-DNA mediated by sigma hole formation and cytotoxicity activity.
Arjmand F; Khursheed S; Roisnel T; Siddique HR
Bioorg Chem; 2020 Nov; 104():104327. PubMed ID: 33142405
[TBL] [Abstract][Full Text] [Related]
4. Surfactant-copper(II) Schiff base complexes: synthesis, structural investigation, DNA interaction, docking studies, and cytotoxic activity.
Lakshmipraba J; Arunachalam S; Solomon RV; Venuvanalingam P; Riyasdeen A; Dhivya R; Akbarsha MA
J Biomol Struct Dyn; 2015; 33(4):877-91. PubMed ID: 24854148
[TBL] [Abstract][Full Text] [Related]
5. Mixed-ligand copper(ii) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity.
Lian WJ; Wang XT; Xie CZ; Tian H; Song XQ; Pan HT; Qiao X; Xu JY
Dalton Trans; 2016 May; 45(22):9073-87. PubMed ID: 27163172
[TBL] [Abstract][Full Text] [Related]
6. Designing, structural elucidation, comparison of DNA binding, cleavage, radical scavenging activity and anticancer activity of copper(I) complex with 5-dimethyl-2-phenyl-4-[(pyridin-2-ylmethylene)-amino]-1,2-dihydro-pyrazol-3-one Schiff base ligand.
Sathiyaraj S; Sampath K; Butcher RJ; Pallepogu R; Jayabalakrishnan C
Eur J Med Chem; 2013 Jun; 64():81-9. PubMed ID: 23644191
[TBL] [Abstract][Full Text] [Related]
7. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
8. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells.
Paul A; Singh P; Kuznetsov ML; Karmakar A; Guedes da Silva MFC; Koch B; Pombeiro AJL
Dalton Trans; 2021 Mar; 50(10):3701-3716. PubMed ID: 33634805
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, spectroscopic and biological activity evaluation of Ni(II), Cu(II) and Zn(II) complexes of schiff base derived from pyridoxal and 4-fluorobenzohydrazide.
Kavitha R; Reddy CVR; Sireesha B
Nucleosides Nucleotides Nucleic Acids; 2021; 40(8):845-866. PubMed ID: 34379029
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of heterobimetallic Sn
Afzal M; Usman M; Al-Lohedan HA; Tabassum S
J Biomol Struct Dyn; 2020 Mar; 38(4):1130-1142. PubMed ID: 30885099
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
Arjmand F; Yousuf I; Hadda Tb; Toupet L
Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes.
Paul A; Anbu S; Sharma G; Kuznetsov ML; Koch B; Guedes da Silva MF; Pombeiro AJ
Dalton Trans; 2015 Dec; 44(46):19983-96. PubMed ID: 26523453
[TBL] [Abstract][Full Text] [Related]
13. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
[TBL] [Abstract][Full Text] [Related]
14. Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα.
Tabassum S; Asim A; Khan RA; Hussain Z; Srivastav S; Srikrishna S; Arjmand F
Dalton Trans; 2013 Dec; 42(48):16749-61. PubMed ID: 24077532
[TBL] [Abstract][Full Text] [Related]
15. RNA-targeted Cu(II)-based potential antitumor drug entity: comprehensive structural, biological {DNA/RNA binding, cleavage, cytotoxicity} and computational studies.
Parveen S; Fatima K; Zehra S; Arjmand F
J Biomol Struct Dyn; 2021 Oct; 39(16):6070-6083. PubMed ID: 32715942
[TBL] [Abstract][Full Text] [Related]
16. New heterobimetallic Cu(II)-Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.
Tabassum S; Afzal M; Arjmand F
J Photochem Photobiol B; 2012 Oct; 115():63-72. PubMed ID: 22884481
[TBL] [Abstract][Full Text] [Related]
17. Copper(ii) l/d-valine-(1,10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity.
Arjmand F; Sharma S; Parveen S; Toupet L; Yu Z; Cowan JA
Dalton Trans; 2020 Jul; 49(28):9888-9899. PubMed ID: 32638779
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
19. Homo- and heteroleptic trimethoxy terpyridine-Cu(ii) complexes: synthesis, characterization, DNA/BSA binding, DNA cleavage and cytotoxicity studies.
Jain S; Bhar K; Kumar S; Bandyopadhyaya S; Tapryal S; Mandal CC; Sharma AK
Dalton Trans; 2020 Apr; 49(13):4100-4113. PubMed ID: 32141470
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of mononuclear copper(II) complexes of acyclic Schiff's base ligands: spectral, structural, electrochemical, antibacterial, DNA binding and cleavage activity.
Jayamani A; Thamilarasan V; Sengottuvelan N; Manisankar P; Kang SK; Kim YI; Ganesan V
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():365-74. PubMed ID: 24317263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
